Lifestyle changes such as physical exercise that increase HDL-C are beneficial; however, pharmacotherapies that increase HDL-C serum concentrations without lowering ApoB have not shown ASCVD risk reduction [25, 26]. Here, APOB is linked to atherosclerosis.